DekaBank Deutsche Girozentrale
AZN icon

DekaBank Deutsche Girozentrale’s AstraZeneca AZN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$732M Hold
3,783,927
– – 1.24% 10
2026
Q1 		$747M Buy
3,783,927
+3,743,056
+9,158% +$722M 1.23% 10
2025
Q4 		$6.81M Hold
40,871
– – 0.01% 524
2025
Q3 		$6.05M Hold
40,871
– – 0.01% 542
2025
Q2 		$5.76M Buy
40,871
+71
+0.2% +$9.95K 0.01% 542
2025
Q1 		$5.91M Sell
40,800
-71
-0.2% -$10.3K 0.01% 535
2024
Q4 		$5.35M Hold
40,871
– – 0.01% 564
2024
Q3 		$6.34M Buy
40,871
+36
+0.1% +$5.81K 0.01% 545
2024
Q2 		$6.39M Buy
40,835
+35
+0.1% +$5.27K 0.01% 535
2024
Q1 		$5.51M Buy
40,800
+144
+0.4% +$19.1K 0.01% 557
2023
Q4 		$5.52M Buy
40,656
+656
+2% +$85.3K 0.01% 559
2023
Q3 		$5.42M Hold
40,000
– – 0.01% 530
2023
Q2 		$5.72M Buy
40,000
+10,000
+33% +$1.47M 0.01% 526
2023
Q1 		$4.22M Hold
30,000
– – 0.01% 570
2022
Q4 		$4.03M Hold
30,000
– – 0.01% 585
2022
Q3 		$3.29M Sell
30,000
-10,000
-25% -$1.27M 0.01% 605
2022
Q2 		$5.23M Hold
40,000
– – 0.02% 520
2022
Q1 		$5.37M Hold
40,000
– – 0.01% 547
2021
Q4 		$4.63M Buy
40,000
+39,702
+13,323% +$4.67M 0.01% 586
2021
Q3 		$35K Sell
298
-57,202
-99% -$6.66M ﹤0.01% 1346
2021
Q2 		$6.82M Hold
57,500
– – 0.02% 452
2021
Q1 		$5.76M Buy
57,500
+17,500
+44% +$1.76M 0.02% 444
2020
Q4 		$4.04M Buy
+40,000
New +$4.24M 0.02% 502

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AZN Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its AstraZeneca (AZN) position steady in Q2 2026 at 3,783,927 shares worth $732M. The position accounts for 1.24% of the portfolio, ranked #10.

DekaBank Deutsche Girozentrale first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $747M in Q1 2026. 910 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 3,783,927 shares of AstraZeneca worth $732M as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 1.24% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #10 holding.
  • DekaBank Deutsche Girozentrale first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
  • DekaBank Deutsche Girozentrale's AstraZeneca position peaked at $747M in Q1 2026.
  • 910 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.